April 24, 2018 / 2:00 PM / in 6 months

BRIEF-Eli Lilly Interested In Immuno-Oncology Deals

April 24 (Reuters) - Eli Lilly and Co:

* ELI LILLY AND CO CEO SAYS PLANS TO SHARE FINDINGS OF STRATEGIC REVIEW OF ANIMAL HEALTH BUSINESS IN JULY

* ELI LILLY SAYS INTERESTED IN BUSINESS DEVELOPMENT INCLUDING DEALS IN IMMUNO-ONCOLOGY AND OTHER CANCER DRUGS Source text for Eikon: Further company coverage: (Reporting By Bill Berkrot)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below